ES2074402B1 - Formulacion farmaceutica conteniendo difenhidramina, talco, calamina y extracto de avena, en una base emulsionada, y sus aplicaciones. - Google Patents

Formulacion farmaceutica conteniendo difenhidramina, talco, calamina y extracto de avena, en una base emulsionada, y sus aplicaciones.

Info

Publication number
ES2074402B1
ES2074402B1 ES09302734A ES9302734A ES2074402B1 ES 2074402 B1 ES2074402 B1 ES 2074402B1 ES 09302734 A ES09302734 A ES 09302734A ES 9302734 A ES9302734 A ES 9302734A ES 2074402 B1 ES2074402 B1 ES 2074402B1
Authority
ES
Spain
Prior art keywords
calamine
oat extract
difenhydramine
talco
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09302734A
Other languages
English (en)
Other versions
ES2074402A1 (es
Inventor
Mas Jose Alberto Vallet
Colomer Jordi Coll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Cusi SA
Original Assignee
Laboratorios Cusi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Cusi SA filed Critical Laboratorios Cusi SA
Priority to ES09302734A priority Critical patent/ES2074402B1/es
Priority to AT94201878T priority patent/ATE162713T1/de
Priority to DE69408294T priority patent/DE69408294T2/de
Priority to EP94201878A priority patent/EP0661047B1/en
Publication of ES2074402A1 publication Critical patent/ES2074402A1/es
Application granted granted Critical
Publication of ES2074402B1 publication Critical patent/ES2074402B1/es
Priority to GR980400897T priority patent/GR3026709T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

FORMULACION FARMACEUTICA CONTENIENDO DIFENHIDRAMINA, TALCO, CALAMINA Y EXTRACTO DE AVENA EN UNA BASE EMULSIONADA, Y SUS APLICACIONES. COMPRENDE: 0,25-2,0% DE DIFENHIDRAMINA CLORHIDRATO O BASE; 0,1-10, 0% DE EXTRACTO COLOIDAL DE AVENA; 0,05-10% DE CALAMINA U OXIDO DE CINC; 1-20% DE TALCO, 0,1-10% DE EMULGENTE; Y, OPCIONALMENTE, UNO O MAS INGREDIENTES SELECCIONADOS ENTRE VISCOSIZANTES, REGULADORES DE LA CONSISTENCIA, PROTECTORES HIDROFUGOS, CONSERVADORES, EMOLIENTES, ANTIOXIDANTES, QUELANTES, SUSTANCIAS LIPIDICAS Y POLIMEROS BIOCOMPATIBLES. APLICACION EN EL TRATAMIENTO TOPICO DE DERMATOSIS DE ORIGEN ALERGICO ACOMPAÑADAS DE PRURITO Y/O DOLOR.
ES09302734A 1993-12-31 1993-12-31 Formulacion farmaceutica conteniendo difenhidramina, talco, calamina y extracto de avena, en una base emulsionada, y sus aplicaciones. Expired - Fee Related ES2074402B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES09302734A ES2074402B1 (es) 1993-12-31 1993-12-31 Formulacion farmaceutica conteniendo difenhidramina, talco, calamina y extracto de avena, en una base emulsionada, y sus aplicaciones.
AT94201878T ATE162713T1 (de) 1993-12-31 1994-06-30 Pharmazeutische zusammensetzung enthaltend diphenhydramin, talc, zinkoxid und haferextrakt in emulsionsträger, sowie deren verwendung
DE69408294T DE69408294T2 (de) 1993-12-31 1994-06-30 Pharmazeutische Zusammensetzung enthaltend Diphenhydramin, Talc, Zinkoxid und Haferextrakt in Emulsionsträger, sowie deren Verwendung
EP94201878A EP0661047B1 (en) 1993-12-31 1994-06-30 Pharmaceutical formulation containing diphenhydramine, talc, calamine and oat extract in an emulsified vehicle and uses thereof
GR980400897T GR3026709T3 (en) 1993-12-31 1998-04-23 Pharmaceutical formulation containing diphenhydramine, talc, calamine and oat extract in an emulsified base and uses thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09302734A ES2074402B1 (es) 1993-12-31 1993-12-31 Formulacion farmaceutica conteniendo difenhidramina, talco, calamina y extracto de avena, en una base emulsionada, y sus aplicaciones.

Publications (2)

Publication Number Publication Date
ES2074402A1 ES2074402A1 (es) 1995-09-01
ES2074402B1 true ES2074402B1 (es) 1996-06-16

Family

ID=8284084

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09302734A Expired - Fee Related ES2074402B1 (es) 1993-12-31 1993-12-31 Formulacion farmaceutica conteniendo difenhidramina, talco, calamina y extracto de avena, en una base emulsionada, y sus aplicaciones.

Country Status (5)

Country Link
EP (1) EP0661047B1 (es)
AT (1) ATE162713T1 (es)
DE (1) DE69408294T2 (es)
ES (1) ES2074402B1 (es)
GR (1) GR3026709T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19515609C1 (de) * 1995-04-28 1996-03-28 Kao Corp Gmbh Mittel zur Behandlung und Pflege von Haaren und Kopfhaut
US5959019A (en) * 1997-08-22 1999-09-28 Colgate-Palmolive Company Topical tale containing compositions
DE19802539B4 (de) * 1998-01-23 2006-05-11 Jarisch, Reinhart, Dr. Verwendung von Diethylentriamin-Pentaessigsäure zum Herstellen einer Schutzcreme gegen Kontaktdermatitis
ATE329576T1 (de) * 1998-08-05 2006-07-15 Lorraine Mignault Hafestroh enthaltende topische lotion
EP1522304B1 (en) 1999-05-06 2009-07-15 Ceapro Inc. Compositions containing avenanthramides from extract of oats
DE10260877A1 (de) * 2002-12-23 2004-07-01 Beiersdorf Ag Stabile zinkoxidhaltige Öl-in-Wasser-Emulsionen
US20070059390A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions for inhibiting or reducing inflammation of skin
CA2819002C (en) * 2010-12-09 2016-07-05 Colgate-Palmolive Company Cleansing composition exhibiting creamy texture and comprising talc and a structuring agent
EP2609908A1 (en) * 2011-12-28 2013-07-03 KPSS-Kao Professional Salon Services GmbH Oxidative dyeing composition
BR112017002192A2 (pt) * 2014-08-05 2018-01-16 Amantin Experts composições protetoras para a pele
CN114209782A (zh) * 2021-12-22 2022-03-22 振德医疗用品股份有限公司 一种造口护理乳膏及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014995A (en) * 1973-09-19 1977-03-29 The Quaker Oats Company Cosmetics containing finely divided oat flour
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
JPS60188315A (ja) * 1984-03-07 1985-09-25 Yamanouchi Pharmaceut Co Ltd グリチルレチン酸配合鎮痒プラスター
US5098717A (en) * 1987-12-09 1992-03-24 Thames Pharmacal Co., Inc. Method of treatment for pruritus
US4929619A (en) * 1988-07-14 1990-05-29 Thames Pharmacal Co., Inc. Anti-infective methods and compositions
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides

Also Published As

Publication number Publication date
EP0661047A1 (en) 1995-07-05
DE69408294D1 (de) 1998-03-05
ES2074402A1 (es) 1995-09-01
GR3026709T3 (en) 1998-07-31
DE69408294T2 (de) 1999-05-20
ATE162713T1 (de) 1998-02-15
EP0661047B1 (en) 1998-01-28

Similar Documents

Publication Publication Date Title
EP0776191A4 (en) METHOD FOR ADMINISTERING MATERIALS IN THE SKIN, AND PREPARATIONS USED THEREOF
DE69424546T2 (de) Thermoplastische elastomere copolymere und diese enthaltendes haar- und hautpflegemittel
DE69420142D1 (de) Thermoplastische Elastomere Copolymere und diese enthaltendes Haar und Hautflegemittel
DE69204978D1 (de) Ölige kosmetische zusammensetzung enthaldend wie verdickungsmittel eine kombination von zwei copolymere sowie rheologische modifizierungsmittel.
ES2074402B1 (es) Formulacion farmaceutica conteniendo difenhidramina, talco, calamina y extracto de avena, en una base emulsionada, y sus aplicaciones.
ATE123943T1 (de) Mittel zur behandlung und vorbeugung von bauchentzündungen, die als wirkstoff zink-l- carnosin-salze oder -komplexe enthalten.
DE69614666D1 (de) Körperpflegemittel und diese mittel enthaltende wischtücher
BR0116832A (pt) Produto desodorante, método cosmético e método de fabricação de composição desodorante
DE69421188D1 (de) Thermoplastische und elastomere silikonpfropfcopolymere und diese enthaltende haar- und hautpflegemittel
ATE59547T1 (de) Mittel zum reduzieren der ausbreitung des sebums.
PT999843E (pt) Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico
BG103780A (en) Antitussive compositions
DE69921119D1 (de) Verwendung von mikrobiziden und spermiziden zusammensetzungen zur inaktivierung von nicht- umhüllten viren
ES2062349T3 (es) Composiciones dentifricas.
FR2719772B1 (fr) Composition cosmétique ou pharmaceutique, notamment dermatologique contenant de la laminarine ou des oligosaccharides dérivés de laminarine.
ES2141736T3 (es) Gel, especialmente para uso terapeutico ocular.
ATE307561T1 (de) Verwendung von spezifischen fettstoffen zur modifizierung der physico-chemischen eigenschaften der haut und/oder der schleimhaut als mittel zur verhinderung oder reduzierung der adhäsion von mikro-organismen darauf
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
IT1240683B (it) Composizione farmaceutica contenente egf
BR9300017A (pt) Composicao cosmetica ou dermatologica
FR2710844B1 (fr) Composition pour le traitement ou la prévention de l'herpès.
JP2000204017A5 (es)
DE69622005D1 (de) Zusammensetzung zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut und eine oder mehrere antimikrobielle Mitteln enthalten

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070102